132 related articles for article (PubMed ID: 38032902)
1. Elevated expression of TUBA1C in breast cancer predicts poor prognosis.
Zhao Y; Wang W; Li J; Du J; Xie Q; Wang M; Liu Z; Huo X; Zhao F; Ren D; Zhao J; Shen G
PLoS One; 2023; 18(11):e0263710. PubMed ID: 38032902
[TBL] [Abstract][Full Text] [Related]
2. TUBA1C expression promotes proliferation by regulating the cell cycle and indicates poor prognosis in glioma.
Gui S; Chen P; Liu Y; Chen Q; Cheng T; Lv S; Zhou T; Song Z; Xiao J; He W; Yuan S; Cheng Z
Biochem Biophys Res Commun; 2021 Nov; 577():130-138. PubMed ID: 34517210
[TBL] [Abstract][Full Text] [Related]
3. Prognostic biomarker TUBA1C is correlated to immune cell infiltration in the tumor microenvironment of lung adenocarcinoma.
Bian T; Zheng M; Jiang D; Liu J; Sun H; Li X; Liu L; Zhang J; Liu Y
Cancer Cell Int; 2021 Mar; 21(1):144. PubMed ID: 33653340
[TBL] [Abstract][Full Text] [Related]
4. High expression of TLR3 in triple-negative breast cancer predicts better prognosis-data from the Fudan University Shanghai Cancer Center cohort and tissue microarrays.
Fan L; Sui XY; Jin X; Zhang WJ; Zhou P; Shao ZM
BMC Cancer; 2023 Apr; 23(1):298. PubMed ID: 37005579
[TBL] [Abstract][Full Text] [Related]
5. TUBA1C is a potential new prognostic biomarker and promotes bladder urothelial carcinoma progression by regulating the cell cycle.
Jiang Y; Zhu C; Huang H; Huang G; Fu B; Xi X
BMC Cancer; 2023 Aug; 23(1):716. PubMed ID: 37528357
[TBL] [Abstract][Full Text] [Related]
6. The oncogenic role of tubulin alpha-1c chain in human tumours.
Hu X; Zhu H; Chen B; He X; Shen Y; Zhang X; Xu Y; Xu X
BMC Cancer; 2022 May; 22(1):498. PubMed ID: 35513790
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of the expression, prognostic significance, and regulation pathway of G2E3 in breast cancer.
Shen Y; Xue J; Yu J; Jiang Y; Bu J; Zhu T; Gu X; Zhu X
World J Surg Oncol; 2022 Dec; 20(1):398. PubMed ID: 36517818
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of TFAP2B in endometrial cancer predicts poor prognosis: A study based on TCGA data.
Wu H; Zhang J
Gynecol Oncol; 2018 Jun; 149(3):592-597. PubMed ID: 29602546
[TBL] [Abstract][Full Text] [Related]
9. Increased E2F2 predicts poor prognosis in patients with HCC based on TCGA data.
Zeng Z; Cao Z; Tang Y
BMC Cancer; 2020 Oct; 20(1):1037. PubMed ID: 33115417
[TBL] [Abstract][Full Text] [Related]
10. Oncogene TUBA1C promotes migration and proliferation in hepatocellular carcinoma and predicts a poor prognosis.
Wang J; Chen W; Wei W; Lou J
Oncotarget; 2017 Nov; 8(56):96215-96224. PubMed ID: 29221200
[TBL] [Abstract][Full Text] [Related]
11. Elevated CDK5R1 predicts worse prognosis in hepatocellular carcinoma based on TCGA data.
Zeng Z; Cao Z; Zhang E; Huang H; Tang Y
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33346796
[TBL] [Abstract][Full Text] [Related]
12. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
Tian QS; Zhang Q; Huang W
Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
[TBL] [Abstract][Full Text] [Related]
13. Elevated expression of mitochondrial transcription elongation factor (TEFM) predicts poor prognosis in low grade glioma-an analysis of the Cancer Genome Atlas (TCGA) dataset.
Li S; Wang W; Zi J; Sun M; Mei W; Yang N; Zhang R; Yu M; Xiong W
Transl Cancer Res; 2020 May; 9(5):3610-3622. PubMed ID: 35117724
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of suppressor of cytokine signaling proteins in human breast Cancer.
Sun M; Tang C; Liu J; Jiang W; Yu H; Dong F; Huang C; Rixiati Y
BMC Cancer; 2021 Jun; 21(1):696. PubMed ID: 34120621
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of RUNX1 in clear cell renal cell carcinoma predicts poor prognosis.
Fu Y; Sun S; Man X; Kong C
PeerJ; 2019; 7():e7854. PubMed ID: 31592165
[TBL] [Abstract][Full Text] [Related]
16. High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma.
Zhang Q; Xia T; Qi C; Du J; Ye C
BMC Cancer; 2022 Jan; 22(1):77. PubMed ID: 35042454
[TBL] [Abstract][Full Text] [Related]
17. High RRM2 expression has poor prognosis in specific types of breast cancer.
Shi SC; Zhang Y; Wang T
PLoS One; 2022; 17(3):e0265195. PubMed ID: 35290409
[TBL] [Abstract][Full Text] [Related]
18. KIF2C is a prognostic biomarker associated with immune cell infiltration in breast cancer.
Liu S; Ye Z; Xue VW; Sun Q; Li H; Lu D
BMC Cancer; 2023 Apr; 23(1):307. PubMed ID: 37016301
[TBL] [Abstract][Full Text] [Related]
19. CDCA8 as an independent predictor for a poor prognosis in liver cancer.
Shuai Y; Fan E; Zhong Q; Chen Q; Feng G; Gou X; Zhang G
Cancer Cell Int; 2021 Mar; 21(1):159. PubMed ID: 33685433
[TBL] [Abstract][Full Text] [Related]
20. High Expression of C8orf76 Is an Independent Predictive Factor of Poor Prognosis in Patients with Breast Cancer.
Wang Y; Dong X
Adv Ther; 2022 Jun; 39(6):2946-2960. PubMed ID: 35482249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
